Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go:
Extended
investment:
£10,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Loanpad is a financial technology entity that provides a user-friendly, lower-risk platform for investors to earn inflation-busting interest through shared short-term property loans. It argues that its portal shields customers from much of the risk of peer-to-peer (P2P) lending by partnering with established property lenders, who take on both higher risk and return. Investors can invest through Loanpad's Classic and/or Premium accounts (both ISA eligible). The Classic account pays 3% and allows daily withdrawals, while the Premium account pays 4% and requires a 60-day notice for withdrawals. Loanpad has over £22 million in funds under management, onboarded over 2,600 registered investors, and witnessed over 150% growth in loans through 2020. It is authorised by the Financial Conduct Authority (FCA). It will use the investment to boost marketing, further develop software capabilities, increase the size of its Interest Cover Fund (ICF), and invest in general working capital.
days to go:
Expired
investment:
£423,060
Assetz Capital is a leading property-secured business marketplace lender in the UK and Europe. It provides loans to small and medium enterprises (SMEs), and property developers in the UK, financed by retail investors, institutional investors, government bodies and banks. The company has arranged loans of over £1 billion since its founding in April 2013. It ranked 53rd out of the UK’s top 100 fastest-growing technology companies for two consecutive years in the Sunday Times Tech Track 100, and funded the equivalent of 1 in 100 UK homes in the last two years. Assetz Capital aims to utilise the investment to fund legal and structuring work around the Coronavirus Business Interruption Loan Schemes (CBILS), have working capital for business development, grow its team, and possibly launch an Initial Public Offering (IPO) in the future.
days to go:
Expired
investment:
£760,600
Solivus is dedicated to decarbonizing the built environment by offering lightweight solar solutions that energize spaces inaccessible to traditional solar due to weight or fixing constraints. As specialists in the emerging lightweight solar market, Solivus addresses a burgeoning UK market worth billions, experiencing increased demand due to soaring energy prices. Their customer-centric approach offers a comprehensive service, encompassing design, installation, finance, energy trading, and ongoing maintenance, aiming for simplicity and convenience for their clients.
days to go:
Expired
investment:
£1,201,011
